TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 28.04%7.08B | ---- | -11.05%5.53B | ---- | 106.55%6.22B | ---- | 36.65%3.01B | ---- | 43.73%2.2B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 5.00%-361M | ---- | -56.38%-380M | ---- | -72.34%-243M | ---- | -29.36%-141M | ---- | 5.22%-109M |
Interest expense - adjustment | ---- | 366.67%182M | ---- | 550.00%39M | ---- | -89.29%6M | ---- | -13.85%56M | ---- | 25.00%65M |
Attributable subsidiary (profit) loss | ---- | -92.54%5M | ---- | 219.05%67M | ---- | --21M | ---- | ---- | ---- | ---- |
Impairment and provisions: | ---- | -14.59%404M | ---- | -32.62%473M | ---- | -27.55%702M | ---- | -7.89%969M | ---- | -19.14%1.05B |
-Impairment of property, plant and equipment (reversal) | ---- | -33.02%142M | ---- | -29.33%212M | ---- | -47.74%300M | ---- | -18.00%574M | ---- | -27.16%700M |
-Impairmen of inventory (reversal) | ---- | 0.38%262M | ---- | -35.07%261M | ---- | 1.77%402M | ---- | 12.22%395M | ---- | 3.53%352M |
Revaluation surplus: | ---- | 96.00%-4M | ---- | -444.83%-100M | ---- | --29M | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | 96.00%-4M | ---- | -444.83%-100M | ---- | --29M | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | -74.82%-486M | ---- | 85.03%-278M | ---- | -16,781.82%-1.86B | ---- | 93.41%-11M | ---- | -77.66%-167M |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 126.09%42M | ---- | -71.28%-161M |
-Loss (gain) from selling other assets | ---- | -74.82%-486M | ---- | 85.03%-278M | ---- | -3,403.77%-1.86B | ---- | -783.33%-53M | ---- | ---6M |
Depreciation and amortization: | ---- | 45.77%2.28B | ---- | -4.81%1.56B | ---- | -6.01%1.64B | ---- | 1.28%1.75B | ---- | 4.23%1.72B |
-Depreciation | ---- | 3.64%1.57B | ---- | -4.19%1.51B | ---- | -6.30%1.58B | ---- | 0.42%1.68B | ---- | 2.70%1.68B |
-Amortization of intangible assets | ---- | 1,269.23%712M | ---- | -20.00%52M | ---- | 1.56%65M | ---- | 30.61%64M | ---- | 113.04%49M |
Exchange Loss (gain) | ---- | 153.77%57M | ---- | -783.33%-106M | ---- | -108.39%-12M | ---- | 3,475.00%143M | ---- | 130.77%4M |
Special items | ---- | -58.09%-215M | ---- | 0.00%-136M | ---- | 58.54%-136M | ---- | -680.95%-328M | ---- | 4.55%-42M |
Operating profit before the change of operating capital | ---- | 34.01%8.94B | ---- | 4.76%6.67B | ---- | 16.96%6.37B | ---- | 15.10%5.44B | ---- | 10.67%4.73B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 81.38%-224M | ---- | -42.54%-1.2B | ---- | -118.09%-844M | ---- | 54.42%-387M | ---- | -893.46%-849M |
Accounts receivable (increase)decrease | ---- | -6.06%124M | ---- | 407.69%132M | ---- | -80.88%26M | ---- | -77.56%136M | ---- | 166.96%606M |
Accounts payable increase (decrease) | ---- | -234.19%-3.38B | ---- | 248.75%2.52B | ---- | 65.60%722M | ---- | 37.11%436M | ---- | 52.88%318M |
Cash from business operations | ---- | -32.75%5.46B | ---- | 29.44%8.12B | ---- | 11.41%6.27B | ---- | 17.15%5.63B | ---- | -0.23%4.8B |
Hong Kong profits tax paid | ---- | ---- | ---- | 200.00%2M | ---- | 0.00%-2M | ---- | ---2M | ---- | ---- |
China income tax paid | ---- | -2.91%-1.31B | ---- | 0.08%-1.27B | ---- | -11.08%-1.27B | ---- | -62.32%-1.15B | ---- | 19.86%-706M |
Special items of business | 25.62%6.01B | ---- | -26.12%4.79B | ---- | 2.02%6.48B | ---- | -2.68%6.35B | ---- | 11.27%6.53B | ---- |
Net cash from operations | 25.62%6.01B | -39.40%4.15B | -26.12%4.79B | 37.06%6.85B | 2.02%6.48B | 11.50%5B | -2.68%6.35B | 9.32%4.48B | 11.27%6.53B | 4.17%4.1B |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | -30.20%245M | ---- | 43.27%351M | ---- | 80.15%245M | ---- | 27.10%136M | ---- | -2.73%107M |
Restricted cash (increase) decrease | ---- | 400.00%3M | ---- | -101.79%-1M | ---- | 800.00%56M | ---- | -700.00%-8M | ---- | -108.33%-1M |
Loan receivable (increase) decrease | ---- | 134.10%491M | --530M | 66.12%-1.44B | ---- | -165.63%-4.25B | ---- | ---1.6B | ---- | --0 |
Decrease in deposits (increase) | ---- | 22.22%220M | ---- | 145.00%180M | ---- | ---400M | ---- | ---- | ---- | ---- |
Sale of fixed assets | ---- | -73.43%157M | ---- | 161.50%591M | ---- | -41.15%226M | ---- | -44.19%384M | ---- | 74.62%688M |
Purchase of fixed assets | -19.27%-1.46B | -51.72%-2.52B | -49.21%-1.23B | -12.92%-1.66B | -89.17%-821M | -40.50%-1.47B | 9.21%-434M | 29.73%-1.05B | 35.05%-478M | 9.20%-1.49B |
Acquisition of subsidiaries | ---- | ---9.71B | ---9.71B | ---- | ---- | ---- | ---- | ---- | ---- | ---2.22B |
Recovery of cash from investments | ---- | --1M | ---- | ---- | ---- | --7M | ---- | ---- | ---- | ---- |
Cash on investment | ---- | 92.09%-120M | ---- | -21.17%-1.52B | ---- | ---1.25B | ---- | ---- | ---- | ---- |
Other items in the investment business | -82.03%294M | -36.65%1.55B | -38.89%1.64B | -40.35%2.44B | 57.47%2.68B | 283.94%4.09B | 78.76%1.7B | 639.58%1.07B | 181.91%951M | 29.73%144M |
Net cash from investment operations | 86.69%-1.17B | -815.60%-9.69B | -572.41%-8.77B | 61.53%-1.06B | 46.60%1.86B | -157.01%-2.75B | 167.65%1.27B | 61.34%-1.07B | 111.50%473M | -172.98%-2.77B |
Net cash before financing | 221.67%4.85B | -195.68%-5.54B | -147.78%-3.98B | 157.82%5.79B | 9.43%8.33B | -34.16%2.25B | 8.83%7.62B | 156.39%3.41B | 299.66%7B | -54.45%1.33B |
Cash flow from financing activities | ||||||||||
New borrowing | -32.05%6.18B | 177.63%9.72B | 1,046.10%9.1B | --3.5B | --794M | ---- | ---- | -21.65%1.47B | -190.53%-526M | 116.26%1.88B |
Refund | -346.71%-9.92B | -173.58%-6.57B | ---2.22B | ---2.4B | ---- | ---- | ---- | 5.72%-2B | ---- | 43.26%-2.12B |
Interest paid - financing | ---- | -366.67%-182M | ---- | -550.00%-39M | ---- | 89.29%-6M | ---- | 13.85%-56M | ---- | -3.17%-65M |
Dividends paid - financing | ---- | -9.87%-1.91B | ---- | -35.67%-1.74B | ---- | -128.88%-1.28B | -191.10%-425M | -13.56%-561M | -50.52%-146M | 6.62%-494M |
Other items of the financing business | 52.75%-43M | 9.62%-47M | -405.56%-91M | ---52M | -132.73%-18M | ---- | 443.75%55M | ---- | 5.88%-16M | ---- |
Net cash from financing operations | -156.65%-3.83B | 214.30%927M | 817.80%6.76B | 40.63%-811M | 272.77%736M | -14.12%-1.37B | 41.40%-426M | -36.33%-1.2B | -266.74%-727M | 74.58%-878M |
Effect of rate | 20.41%-39M | 46.90%-77M | -28.95%-49M | -253.66%-145M | -660.00%-38M | -173.33%-41M | 64.29%-5M | -150.00%-15M | -187.50%-14M | -3.23%30M |
Net Cash | -63.29%1.02B | -192.65%-4.61B | -69.43%2.77B | 466.21%4.98B | 26.15%9.07B | -60.28%879M | 14.65%7.19B | 389.60%2.21B | 186.74%6.27B | 184.64%452M |
Begining period cash | -45.92%5.52B | 89.88%10.21B | 89.88%10.21B | 18.47%5.38B | 18.47%5.38B | 93.93%4.54B | 93.93%4.54B | 25.94%2.34B | 25.94%2.34B | -21.30%1.86B |
Cash at the end | -49.74%6.5B | -45.92%5.52B | -10.24%12.93B | 89.88%10.21B | 22.90%14.41B | 18.47%5.38B | 36.36%11.72B | 93.93%4.54B | 111.70%8.6B | 25.94%2.34B |
Cash balance analysis | ||||||||||
Bank deposits | -53.45%3.31B | -21.21%3.31B | 610.60%7.11B | 600.83%4.21B | --1B | -40.00%600M | ---- | 0.00%1B | ---- | 0.00%1B |
Cash and cash equivalent balance | -53.45%3.31B | -21.21%3.31B | 610.60%7.11B | 600.83%4.21B | --1B | -40.00%600M | ---- | 0.00%1B | ---- | 0.00%1B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte · Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte · Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte · Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte · Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte · Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.